Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)
Clinical trial NCT07481747 · RECRUITING
Trial details
- NCT number
- NCT07481747
- Sponsor
- Hudson Biotech
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2027-02-14
- Enrollment
- 2539
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.